Chemistry Reference
In-Depth Information
110. Laube, B.; Maksay, G.; Schemm, R.; Betz, H. Modulation of glycine receptor function:
A novel approach for therapeutic intervention at inhibitory synapses? Trends Pharmacol.
Sci., 2002, 23: 519-527.
111. Harvey, R. J.; Depner, U. B.; W¨ssle, H.; Ahmadi, S.; Heindl, C.; Reinold, H.; Smart, T.
G.; Harvey, K.; Sch¨ tz, B.; Abo-Salem, O. M.; Zimmer, A.; Poisbeau, P.; Welzl, H.;
Wolfer, D. P.; Betz, H.; Zeilhofer, H. U.; M¨ ller, U. GlyR a3: An essential target for
spinal PGE2-mediated inflammatory pain sensitization. Science, 2004, 304: 884-887.
112. Huang, S. H.; Duke, R. K.; Chebib, M.; Sasaki, K.; Wada, K.; Johnston, G. A. R.
Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant
a
1
b
2
g
2L
GABA
A
receptors. Eur. J. Pharmacol., 2004, 494: 131-138.
113. Kondratskaya, E. L.; Fisyunov, A. I.; Chatterjee, S. S.; Krishtal, O. A. Ginkgolide B
preferentially blocks chloride channels formed by heteromeric glycine receptors in
hippocampal pyramidal neurons of rat. Brain Res. Bull., 2004, 63: 309-314.
114. Chatterjee, S. S.; Kondratskaya, E. L.; Krishtal, O. A. Structure-activity studies with
Ginkgo biloba extract constituents as receptor-gated chloride channel blockers and
modulators. Pharmacopsychiatry, 2003, 36(Suppl. 1): S68-S77.
115. Jaracz, S.; Nakanishi, K.; Jensen, A. A.; Strømgaard, K. Ginkgolides and glycine
receptors: A structure-activity relationship study. Chem. Eur. J., 2004, 10: 1507-1518.
116. Jensen, A. A.; Kristiansen, U. Functional characterisation of the human a1 glycine
receptor in a fluorescence-based membrane potential assay. Biochem. Pharmacol., 2004,
67: 1789-1799.
117. Gavish, M.; Bachman, I.; Shoukrun, R.; Katz, Y.; Veenman, L.; Weisinger, G.; Weizman,
A. Enigma of the peripheral benzodiazepine receptor. Pharmacol. Rev., 1999, 51:
629-650.
118. Veenman, L.; Gavish, M. Peripheral-type benzodiazepine receptors: their implication in
brain disease. Drug Develop. Res., 2000, 50: 355-370.
119. Amri, H.; Ogwuegbu, S. O.; Boujrad, N.; Drieu, K.; Papadopoulus, V. In vivo regulation
of the peripheral-type benzodiazepine receptor and glucocorticoid synthesis by the
Ginkgo biloba extract EGb and isolated ginkgolides. Endocrinology, 1996, 137: 5707-
5718.
120. Amri, H.; Drieu, K.; Papadopoulos, V. Ex vivo regulation of adrenal cortical cell steroid
and protein synthesis, in response to adrenocorticotropic hormon stimulation by the
Ginkgo biloba extract EGb 761 and isolated ginkgolide B. Endocrinology, 1997, 138:
5415-5426.
121. Drieu, K. (SCRAS). Ginkgolides for inhibition of membrane expression of benzodia-
zepine receptors. U.S. Patent 6,274,621, 2001.
122. Amri, H.; Drieu, K.; Papadopoulos, V. Transcriptional suppression of adrenal cortical
peripheral-type benzodiazepine receptor gene and inhibition of steroid synthesis by
ginkgolide B. Biochem. Pharmacol., 2003, 65: 717-729.
123. Amri, H.; Drieu, K.; Papadopoulos, V. Use of ginkgolide B and a ginkgolide-activated
response element to control gene transcription: example of the adrenocortical fperipheral-
type benzodiazepine receptor. Cell. Mol. Biol., 2002, 48: 633-639.
124. Pietri, S.; Maurelli, E.; Drieu, K.; Culcasi, M. Cardioprotective and antioxidant effects of
the terpenoid constituents of Ginkgo biloba extract. J. Mol. Cell. Cardiol., 1997, 29:
833-742.
Search WWH ::
Custom Search